W
William Borkowsky
Researcher at New York University
Publications - 215
Citations - 10325
William Borkowsky is an academic researcher from New York University. The author has contributed to research in topics: Viral load & Vaccination. The author has an hindex of 51, co-authored 214 publications receiving 9992 citations. Previous affiliations of William Borkowsky include Cornell University & State University of New York Upstate Medical University.
Papers
More filters
Journal ArticleDOI
Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.
John H. Beigel,Evgenia Aga,Marie-Carmelle Elie-Turenne,Josalyn L. Cho,Pablo Tebas,Carol L. Clark,Jordan P. Metcalf,Caroline P. Ozment,Kanakatte Raviprakash,Joy Beeler,H Preston Holley,Stephanie Warner,Carla Chorley,H. Clifford Lane,Michael Hughes,Richard T. Davey,Michelle A. Barron,Aveh Bastani,Philippe R. Bauer,William Borkowsky,Charles B. Cairns,Jaime G. Deville,Marie-Carmelle Elie,Carl J. Fichtenbaum,Robert W. Finberg,Mamta K. Jain,David Kaufman,Michael Z. Lin,John Lin,Ryan C. Maves,Lee E. Morrow,Minh-Hong Nguyen,Pauline Park,Christopher Polk,Adrienne G. Randolph,Suchitra Rao,Lewis Rubinson,Christina Schofield,Shmuel Shoham,Erika Stalets,Renee D Stapleton +40 more
TL;DR: This randomised, double-blind, phase 3 trial at 41 US medical centres to assess the efficacy of high-titre anti-influenza plasma (haemagglutination inhibition antibody titre ≥1:80) compared with standard low-Titre plasma to improve outcomes in patients with severe influenza A infection showed low conditional power.
Journal ArticleDOI
Bone Mineral Density in Children and Adolescents with Perinatal HIV Infection
Linda A. DiMeglio,Jiajia Wang,George K. Siberry,Tracie L. Miller,Mitchell E. Geffner,Rohan Hazra,William Borkowsky,Janet S Chen,Laurie B. Dooley,Kunjal Patel,Russell B. Van Dyke,Roger A. Fielding,Yared Gurmu,Denise L. Jacobson +13 more
TL;DR: Rates of low BMD in HIV+ children were greater than expected based on normal population distributions, partially explained by delays in growth.
Journal ArticleDOI
Safety of 2 Recombinant Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Vaccines in Neonates Born to HIV-1-Infected Women
Coleen K. Cunningham,Diane W. Wara,Minhee Kang,T. Fenton,E. Hawkins,J. McNamara,Lynne M. Mofenson,A. M. Duliege,D. Francis,Elizabeth J. McFarland,William Borkowsky,T. Hastings,N. Deygoo,M. Lugo,M. Rivera,K. A. Contello,S. Nachman,M. Davi,C. R. Salbenblatt,M. J. Levin,R. Galvin,M. Mirochnick,Alex Dorenbaum,Steven A Spector,W. M. Dankner,L. Frenkel,A. J. Melvin,K. M. Mohan,K. Mooney,C. Vincent,M. Silio,E. McBride,J. Pitt,P. LaRussa,Ellen G. Chadwick,D. F. Cloutier,J. Lambert,N. Hutton,B. Murante,S. Laverty,J L Sullivan,K. Luzuriaga,Ross E. McKinney,M. Valentine,W. T. Shearer,Marilyn Doyle +45 more
TL;DR: Both vaccines were safe and well tolerated in neonates, and there was no evidence of accelerated immunologic decline in HIV-infected infants.
Journal ArticleDOI
Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1
TL;DR: Human MGKs have a CD4 receptor capable of binding HIV-1, which can infect cells representative of the MGK lineage, as determined by anti-gp120 and anti-CD41 staining.
Journal ArticleDOI
Enhancement of lymphocyte and macrophage function in vitro by lithium chloride
TL;DR: Lithium chloride, an inhibitor of adenylate cyclase, augmented several in vitro immune reactions and reversed the effect of Prostaglandin E1, suggesting that its actions on lymphocytes may be mediated, at least in part, by inhibitingAdenylates cyclase.